Transoral Robotic Surgery (TORS) is increasingly used for oropharyngeal neoplasms and obstructive sleep apnea. Post-operative pain and bleeding remain concerns. Ketorolac has proved to be a safe alternative or addition to narcotics in other operations, but has not been thoroughly evaluated in TORS. A retrospective review was carried out on all TORS cases at our institution between April 2012 and March 2019, with the vast majority of cases performed starting in 2017. Post-operative bleed rates were compared between those who received Ketorolac and those who did not. Secondary outcomes evaluated included post-operative pain scores and need for feeding tube upon discharge. A total of 81 TORS cases were evaluated, with 37 patients receiving Ketorolac. Six (7.4%) patients reported post-operative bleeding, with one major and five minor bleeds. The patient with major bleeding requiring operative intervention did not receive Ketorolac. All five patients with minor bleeding received Ketorolac, but no bleeds occurred in the immediate post-operative setting while receiving Ketorolac. The average time of bleeding was 8 days post-operative. There were no significant differences in pain scores or time to feeding tube removal. This preliminary study shows that Ketorolac use in the postoperative pain management after TORS does not increase major bleeding risk without benefits in pain management. There was increased risk of minor bleeding not requiring intervention, but this was not significant. Future prospective studies are needed to determine if it improves pain and swallowing and decreases narcotic requirements following TORS.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Private access to authors on secure, password protected, database.
Chen MM, Roman SA, Kraus DH, Sosa JA, Judson BL (2014) Transoral robotic surgery: a population-level analysis. Otolaryngol Head Neck Surg 150:968–975. https://doi.org/10.1177/0194599814525747
Hay A, Migliacci J, Karassawa Zanoni D, Boyle JO, Singh B, Wong RJ et al (2018) Haemorrhage following transoral robotic surgery. Clin Otolaryngol 43:638–644. https://doi.org/10.1111/coa.13041
Richmon JD, Feng AL, Yang W, Starmer H, Quon H, Gourin CG (2014) Feasibility of rapid discharge after transoral robotic surgery of the oropharynx. Laryngoscope 124:2518–2525. https://doi.org/10.1002/lary.24748
Asher SA, White HN, Kejner AE, Rosenthal EL, Carroll WR, Magnuson JS (2012) Hemorrhage after transoral robotic assisted surgery. Otolaryngol Head Neck Surg 147:P59–P69. https://doi.org/10.1177/0194599812451438a72
Asher SA, White HN, Kejner AE, Rosenthal EL, Carroll WR, Magnuson JS (2013) Hemorrhage after transoral robotic-assisted surgery. Otolaryngol Head Neck Surg 149:112–117. https://doi.org/10.1177/0194599813486254
Zenga J, Suko J, Kallogjeri D, Pipkorn P, Nussenbaum B, Jackson RS (2017) Postoperative hemorrhage and hospital revisit after transoral robotic surgery. Laryngoscope 127:2287–2292. https://doi.org/10.1002/lary.26626
Wick EC, Grant MC, Wu CL (2017) Postoperative multimodal analgesia pain management with nonopioid analgesics and techniques: a review. JAMA Surg 152:691–697. https://doi.org/10.1001/jamasurg.2017.0898
Maslin B, Lipana L, Roth B, Kodumudi G, Vadivelu N (2017) Safety considerations in the use of ketorolac for postoperative pain. Curr Drug Saf 12:67–73. https://doi.org/10.2174/1574886311666160719154420
Gobble RM, Hoang HLT, Kachniarz B, Orgill DP (2014) Ketorolac does not increase perioperative bleeding: a meta-analysis of randomized controlled trials. Plast Reconstr Surg 133:741–755. https://doi.org/10.1097/01.prs.0000438459.60474.b5
Cardwell M, Siviter G, Smith A (2005) Non-steroidal anti-inflammatory drugs and perioperative bleeding in paediatric tonsillectomy. Cochrane Database Syst Rev 16:CD003591. https://doi.org/10.1002/14651858.CD003591.pub2
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381. https://doi.org/10.1016/j.jbi.2008.08.010
Topf MC, Vo A, Tassone P, Shumrick C, Luginbuhl A, Cognetti DM et al (2017) Unplanned readmission following transoral robotic surgery. Oral Oncol 75:127–132. https://doi.org/10.1016/j.oraloncology.2017.11.009
Mandal R, Duvvuri U, Ferris RL, Kaffenberger TM, Choby GW, Kim S (2015) Analysis of post-transoral robotic-assisted surgery hemorrhage: Frequency, outcomes, and prevention. Head Neck 38:E776–E782. https://doi.org/10.1002/hed.24101
Pollei TR, Hinni ML, Moore EJ, Hayden RE, Olsen KD, Casler JD et al (2013) Analysis of postoperative bleeding and risk factors in transoral surgery of the oropharynx. JAMA Otolaryngol Head Neck Surg 139:1212–1218. https://doi.org/10.1001/jamaoto.2013.5097
Aubry K, Vergez S, de Mones E, Moriniere S, Choussy O, Malard O et al (2016) Morbidity and mortality revue of the French group of transoral robotic surgery: a multicentric study. J Robot Surg 10:63–67. https://doi.org/10.1007/s11701-015-0542-z
Gleysteen J, Troob S, Light T, Brickman D, Clayburgh D, Andersen P et al (2017) The impact of prophylactic external carotid artery ligation on postoperative bleeding after transoral robotic surgery (TORS) for oropharyngeal squamous cell carcinoma. Oral Oncol 70:1–6. https://doi.org/10.1016/j.oraloncology.2017.04.014
The authors did not receive support or funding for this study.
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Our retrospective study was conducted using data obtained for clinical purposes. The Indiana University Institutional Review Board gave an official waiver of ethical approval.
Consent to participate
Consent for publication
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Sandelski, M.M., Drejet, S.M., Zimmer, D. et al. Evaluating the risks and benefits of ketorolac in transoral robotic surgery. J Robotic Surg (2021). https://doi.org/10.1007/s11701-021-01190-y
- Transoral robotic surgery
- Postoperative hemorrhage
- Postoperative bleed
- Oropharyngeal squamous cell carcinoma